Mylan Pharmaceuticals Inc. recalls Diltiazem HCl Extended-Release Capsules, USP 120 mg 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV
Recalled September 19, 2018 · FDA recall D-1187-2018 · Mylan Pharmaceuticals
Hazard
Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound. · FDA Class III
Units
656 500-count bottles
Sold at
Distributed Nationwide in the US
Description
Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.
Product
Diltiazem HCl Extended-Release Capsules, USP 120 mg 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-05
Manufacturer(s)
Mylan Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →